Pfizer's coronavirus vaccine shows promise: What does a two-dose shot entail?
November 10 2020, 08:00
Pfizer and BioNTech's coronavirus vaccine inched a step closer toward approval on Monday, with the company announcing 90% efficacy in phase 3 clinical trial.
Pfizer and BioNTech's coronavirus vaccine inched a step closer toward approval on Monday, with the company announcing 90% efficacy in phase 3 clinical trial.
Source:
FOX News